Abstract:Objective: To evaluate the clinical safety and diagnostic efficacy of domestic gadoxetate disodium (GdEOBDTPA). Methods: The imaging data from patients with space-occupying liver lesions who underwent GdEOBDTPA enhanced magnetic resonance examination at West China Hospital of Sichuan University between January 2020 and September 2020 were analyzed retrospectively. Clinical indicators were evaluated by the incidental condition of transient severe respiratory motion artifacts (TSM) in the arterial phase to assess the safety profile.The differences in quantitative and qualitative indicators for the risk factors of TSM in the arterial phase between the TSM group and the non-TSM group were compared by t-test and χ2 test. Observational indicators of the accuracy of diagnostic procedures: The 2018 version of the Liver Imaging Reporting and Data System (LI-RADS) was used to evaluate the main signs, auxiliary signs, and LR grades of lesions. Postoperative pathological findings were used as the gold standard for evaluating and diagnosing hepatocellular carcinoma (HCC). Simultaneously, the relative enhancement degree of the liver, the contrast between the lesion and the liver, and the cholangiography in the hepatobiliary phase were evaluated. The McNemar test was used to compare the differences in the diagnostic efficiency of physician 1 and physician 2 in the diagnosis of hepatocellular carcinoma according to the 2018 version of LI-RADS. Results: A total of 114 cases were included in this study. The incidence rate of TSM was 9.6% (11/114). Age [(53.8 ± 11.3) years vs. (55.4 ± 15.4) years, t = 0.465, P = 0.497], body weight [(65.8 ± 11.1) kg vs. (60.8 ± 7.6) kg, t = 1.468, P = 0.228], body mass index [(23.9 ± 3.1) kg/m(2) vs. (23.4 ± 3.0) kg/m(2), t = 0.171, P = 0.680], liver cirrhosis ratio (39 cases vs. 4 cases, χ (2) =1.776, P = 0.183), proportion of mild to moderate pleural effusion (32 cases vs. 4 cases, χ (2) = 0.000, P = 0.986), and proportion of mild to moderate ascites (47 cases vs. 5 cases χ (2) = 0.000, P = 0.991) had no statistically significant difference between the groups of non-TSM and TSM patients. According to the 2018 version of LI-RADS for the LR5 category, there was no statistically significant difference between the two physicians' HCC diagnoses in terms of sensitivity (91.4% vs.86.4%, χ (2) = 1.500, P = 0.219), specificity (72.7 % vs. 69.7%, χ (2) = 0.000, P = 1.000), positive predictive value (89.2% vs. 87.5%, χ (2) = 2.250, P = 0.125), negative predictive value (77.4% vs. 67.6%, χ (2) = 2.250, P = 0.125), and accuracy (86.0% vs. 81.6%, χ (2) = 0.131, P = 0.125). According to physicians 1 and 2 film review results, 91.2% (104/114) and 89.5% (102/114) of the contrast agent were discharged into the common bile duct or duodenum, respectively. In addition, 86.0% (98/114) of the patients had good liver enhancement, and 91.2% (104/114) of the lesions showed low signals relative to the liver background. Conclusion: Domestic gadoxetate disodium has a good clinical safety profile and diagnostic efficacy.

Comparison of Gadoxetate Disodium and Gadopentetate Dimeglumine in Dynamic Contrast-Enhanced Liver MRI:an Intra-Individual Comparative Study

Comparative Study of Using Gd-EOB-DTPA and Gd-DTPA As MR Contrast Agent for Hepatic Parenchyma and Vessles Enhacement in the Same Patient with Cirrhosis

The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor

Study of Clinical Application of Hepatic-Biliary Specific MR Contrast Agent(gd-Eob-dtpa) in the Diagnosis of Focal Hepatic Lesions

Preliminary study of hepatocyte-specific MR contrast agent in the evaluation of liver function

[Evaluation of clinical safety and diagnostic efficacy of domestic liver-specific magnetic resonance contrast agent (gadoxetate disodium)]

Preliminary Study of Hepatobiliary Specific Contrast Agent Gd-EOB-DTPA Used in Biliary Tree Imaging

Gd-EOB-DTPA-enhanced Magnetic Resonance Imaging for Focal Liver Lesions in Chinese Patients: a Multicenter, Open-Label, Phase III Study.

Comparative Study of Dynamic Enhanced MRI and Dual Phase Dual-SCT Scanning in the Diagnosis of Liver Metastases

Evaluation of Multiple-Arterial-phase Aquisition and Image Quality in Gadoxetate Acid Disodium Enhanced Liver MRI Using Differential Sub-Sampling with Cartesian Ordering Technique:A Comparative Study with Single Arterial Phase

Gd+-EOB-DTPA-enhanced MRI evaluation of colorectal liver metastases and chemotherapy-induced fatty liver

Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions.

A Compared Study on Gd+-EOB-DTPA and Gd+-DTPA-enhanced MRI in Detection of Hepatocellular Carcinoma

Improved Display of Abdominal Contrast-Enhanced MRA Using Gadobutrol: Comparison with Gd-DTPA.

[Controlled Study of Gadobenate Dimeglumine Versus Gadopentetate in Breast Tumor MR Dynamic Enhancement Scanning].

Application of hepatobiliary-specific MRI contrast agent Gd-EOB-DTPA in preoperative evaluation of hepatobiliary patients

Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v

Preoperative Evaluation of Colorectal Liver Metastases: Comparison of Gadopentetate Dimeglumine and Gadoxetic-Acid-enhanced 1.5-T MRI

Influence of Different Contrast Agents on Dynamic Contrast-Enhanced MRI Ktrans in Cerebral Metastases: Comparison between 1.0 M Gadobutrol and 0.5M Gadopentetate Dimeglumine

Application of tissue-specific magnetic resonance imaging contrast agent gadolinium ethoxybenzyl dimeglumine on precision hepatic surgery

Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.